Remembering Dale Schenk
Dale Schenk was born May 10, 1957 in Glendora, California to Walter Bernard Schenk, a firefighter, and Rosemary Schenk, a family therapist. He received an undergraduate degree in biology in 1979 from the University of California at San Diego, where...
Read More
Amyloidosis Voice at Global Genes Summit
On September 22nd and 23rd two members of the Amyloidosis Research Consortium were invited speakers at the Global Genes 5th Annual RARE Patient Advocacy Summit event in Huntington Beach, California. ARC CEO Isabelle Lousada delivered a presentation on The Patient's Role in...
Read More
Cardiac Amyloidosis
Calling all Cardiologists
ARC is supporting a Satellite Symposium at the Heart Failure Society of America (HFSA) Meeting, 4-6pm, September 17, 2016. Cardiologists miss the diagnosis of amyloidosis more frequently than any other discipline. Don't be one of them. Join ARC for an...
Read More
Seminal ARC Manuscript Published
Amyloidosis Research Consortium Announces Publication of Seminal Manuscript in Peer-Reviewed Journal Leukemia Encouraging Use of NT-proBNP as Endpoint in Clinical Trials. International AL amyloidosis expert community agrees N-terminal pro-brain natriuretic peptide (NT-proBNP) is analytically validated and clinically qualified to be...
Read More
Report from International Symposium on Amyloidosis
The 2016 International Symposium on Amyloidosis was held in Uppsala, Sweden in early July. Over the years the meeting has grown in size and it was impressive to see over 400 scientists and experts come together to spend three days...
Read More

320 Nevada Street, Suite 210 Newton, MA 02460 USA | 617-467-5170

ARC is a 501(c)(3) nonprofit organization